| Name | Judges Scientific |
|---|---|
| Epic | JDG |
| Isin | GB0032398678 |
| Index | UK250 UK350 |
| Industry | Industrial Engineering |
| Latest share price | 8,266.67p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £549.10 | Debt ratio | n/a |
| Shares in issue | 6.64 | Debt-to-equity ratio | n/a |
| P/E ratio | 24.3 | Assets / equity ratio | n/a |
| Total dividends per share | 95.00p | Price to book value | n/a |
| Dividend yield | 0.9 | ROCE | 1250.38 |
| Dividend cover | 4.36 | EPS growth | 3 |
| Earning per share | 145.8 | 52-week high / low | 8,200.00p / 12,250.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-06-06 | 2024-07-05 | 68.00p |
| Interim | 2023-10-05 | 2023-11-03 | 27.00p |
| Final | 2023-06-08 | 2023-07-07 | 59.00p |
| Interim | 2022-10-06 | 2022-11-04 | 22.00p |
| Final | 2022-06-09 | 2022-07-08 | 47.00p |
| Interim | 2021-10-07 | 2021-11-05 | 19.00p |
| Final | 2021-06-10 | 2021-07-09 | 38.50p |
| Interim | 2020-10-08 | 2020-11-06 | 16.50p |
| Final | 2020-06-04 | 2020-07-03 | 35.00p |
| Company name | Judges Scientific |
|---|---|
| Address | 52C Borough High Street, London, United Kingdom, SE1 1XN |
| Telephone | +44 (0)203 829 6970 |
| Website | http://www.judges.uk.com/ |
| Director | Position |
|---|---|
| Mr David Cicurel | CEO |
| Hon Alexander Hambro | Chairman |
| Mr Ralph Elman | Non-Executive Director |
| Mr Bradley Leonard Ormsby | Group Finance Director |
| Ms Lushani Kodituwakku | Independent Non-Executive Director |
| Mr Charles Holroyd | Independent Non-Executive Director |
| Dr Tim Prestidge | Group Business Development Director |
| Mr Mark Lavelle | Chief Operating Officer |
| Ms Susan Nyman | Vice Chairman and CEO |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 90.4 | 98 | 23.77 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 118.2 | 119.3 | 39.29 |
| Inventory / work in progress | 26.5 | 22.3 | 14.13 |
| Trade and other receivables | 25.1 | 25.6 | 17.15 |
| Cash and equivalents | 13.7 | 20.8 | 18.41 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 183.5 | 188 | 88.98 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 35 | 71.8 | 26.64 |
| Long term liabilities | 65.9 | 61.7 | 18.94 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 100.9 | 133.5 | 45.58 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 82.6 | 54.5 | 43.39 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.3 | 0.3 | 0.32 |
| Minority interests | 0.2 | 0.2 | 0.62 |
| Retained earnings | 37.5 | 32.7 | 23.79 |
| Share premium account | 17.7 | 17.2 | 16.67 |
| Total equity | 82.6 | 54.5 | 43.39 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 21.6 | 18.2 | 15.62 |
| Pre-tax profit | 13.4 | 16 | 14.86 |